2m 2m 2m 2m 2m 2m 2m
IBIO (IBIO)
NASDAQ
$1.68+$0.03 (+1.58%)
Price as of Jun 23, 2026 7:40 PM EDT- $86.4MMarket Cap
- 120.59%1-Year Change
- BiotechnologyIndustry
IBIO (IBIO)
$1.68+$0.03 (+1.58%)
IBIO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.65 | ||
Change | +$0.05 (+2.96%) | ||
Open | $1.70 | ||
High | $1.75 | ||
Low | $1.65 | ||
Previous Close | $1.74 | ||
Volume | 931,406 | ||
30-Day Average Volume | 839,735 | ||
1-Week Change | 5.45% | ||
1-Month Change | -5.43% | ||
1-Year Change | 144.24% | ||
3-Year Change | -86.62% | ||
5-Year Change | -99.76% | ||
Fundamentals | |||
Shares Outstanding | 49.7M | ||
Total Assets | $85.8M | ||
Market Cap | $86.4M | ||
Enterprise Value | $39.6M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$7.7M | ||
Free Cash Flow | -$6.1M | ||
EBIT | -$7.7M | ||
EBITDA | -$7.7M | ||
Net Working Capital | $70.7M | ||
EPS | -$0.06 | ||
Enterprise Value/EBITDA | -5 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -29 | ||
PEG | -1 | ||
Price/Free Cash Flow | -14 | ||
Price/Operating Cash Flow | -14 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 20 | ||
Last Split Date | 11/29/2023 | ||
Earnings & Revenue